Metformin Induces Cytotoxicity by Down‐Regulating Thymidine Phosphorylase and Excision Repair Cross‐Complementation 1 Expression in Non‐Small Cell Lung Cancer Cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Basic & Clinical Pharmacology & Toxicology

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bcpt.12052PMID 23362830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

  2012cited by this paper
• Platelet-derived endothelial cell growth factor/thymidine phosphorylase inhibitor augments radiotherapeutic efficacy in experimental colorectal cancer.

  2012cited by this paper
• Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells.

  2012cited by this paper
• Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression.

  2012cited by this paper
• Up-Regulation of Extracellular Signal-Regulated Kinase 1/2-Dependent Thymidylate Synthase and Thymidine Phosphorylase Contributes to Cisplatin Resistance in Human Non–Small-Cell Lung Cancer Cells

  2011cited by this paper
• Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

  2011cited by this paper
• Understanding the benefit of metformin use in cancer treatment

  2011cited by this paper
• Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase‐9 activation through a calcium and protein kinase Cα‐dependent pathway: phorbol‐12‐myristate‐13‐acetate‐induced/extracellular signal‐regulated kinase/activator protein‐1

  2010cited by this paper
• Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo

  2010cited by this paper
• Methylation Markers for Small Cell Lung Cancer in Peripheral Blood Leukocyte DNA

  2010cited by this paper
• Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

  2010cited by this paper
• Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase

  2010cited by this paper
• Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin

  2010cited by this paper
• Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

  2010cited by this paper
• Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

  2010cited by this paper
• Arachidin-1, a peanut stilbenoid, induces programmed cell death in human leukemia HL-60 cells.

  2010cited by this paper
• Is it Time to Test Metformin in Breast Cancer Clinical Trials?

  2009cited by this paper
• 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression.

  2009cited by this paper
• Metformin induces unique biological and molecular responses in triple negative breast cancer cells

  2009cited by this paper
• Roles of MKK1/2-ERK1/2 and Phosphoinositide 3-Kinase–AKT Signaling Pathways in Erlotinib-Induced Rad51 Suppression and Cytotoxicity in Human Non–Small Cell Lung Cancer Cells

  2009cited by this paper
• Metformin in breast cancer: time for action.

  2009cited by this paper
• Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

  2009cited by this paper
• Insulin-lowering effects of metformin in women with early breast cancer.

  2008cited by this paper
• Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators

  2008cited by this paper
• The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

  2008cited by this paper
• In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

  2008cited by this paper
• Thymidine phosphorylase inhibits the expression of proapoptotic protein BNIP3.

  2008cited by this paper
• ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.

  2007cited by this paper
• Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

  2007cited by this paper
• Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages.

  2007cited by this paper
• ERCC1-specific immunostaining in non-small-cell lung cancer.

  2007cited by this paper
• Biosynthesis enhancement and antioxidant and anti-inflammatory activities of peanut (Arachis hypogaea L.) arachidin-1, arachidin-3, and isopentadienylresveratrol.

  2006cited by this paper
• Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture.

  2006cited by this paper
• Protection against DNA damage‐induced apoptosis by the angiogenic factor thymidine phosphorylase

  2006cited by this paper
• Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents.

  2005cited by this paper
• Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment.

  2005cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• Germination of peanut kernels to enhance resveratrol biosynthesis and prepare sprouts as a functional vegetable.

  2005cited by this paper
• Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin.

  2005cited by this paper
• Excision repair cross complementing-group 1: gene expression and platinum resistance.

  2004cited by this paper
• Thymidine phosphorylase inhibits apoptosis induced by cisplatin.

  2003cited by this paper
• SU5416 sensitizes ovarian cancer cells to cisplatin through inhibition of nucleotide excision repair

  2003cited by this paper
• Epidermal Growth Factor and Ionizing Radiation Up-regulate the DNA Repair Genes XRCC1 and ERCC1 in DU145 and LNCaP Prostate Carcinoma through MAPK Signaling

  2003cited by this paper
• Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

  2002cited by this paper
• Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis

  2002cited by this paper
• Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity.

  2002cited by this paper
• The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma

  2000cited by this paper
• Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.

  2000cited by this paper
• Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.

  2000cited by this paper
• Molecular mechanism of nucleotide excision repair.

  1999cited by this paper
• ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

  1998cited by this paper
• Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes

  1997cited by this paper
• Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.

  1996cited by this paper
• The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue.

  1954cited by this paper

• Modulation of the Antitumor Response to Metformin, Caffeine, and Sodium Dichloroacetate by the Hypoxic Microenvironment in Lung Cancer Cells

  2025cites this paper
• Bioactivity assessment of high potency arachidin mixture from large-scale peanut hairy root culture medium

  2024cites this paper
• A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition

  2023cites this paper
• Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells

  2023cites this paper
• Metformin Intervention—A Panacea for Cancer Treatment?

  2022cites this paper
• Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies

  2021cites this paper
• Metformin: an old drug against old age and associated morbidities.

  2020cites this paper
• Antitumor Activity of Combination Therapy with Metformin and Trametinib in Non-Small Cell Lung Cancer Cells

  2020cites this paper
• Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities

  2019cites this paper
• Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells

  2018cites this paper
• A Potential Role for the Anti-diabetic Drug Metformin in the Treatment of Platinum Resistant Ovarian Cancer

  2018cites this paper
• Anti-Cancer and Bioavailability of Arachidin-1 and Arachidin-3 in Colon Cancer Cells

  2017cites this paper
• Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies

  2017cites this paper
• Antineoplastic activity of metformin on the A 549 human lung carcinoma cell line in vitro

  2017cites this paper
• Research of the effects of metformin on the proliferation of non-invasive bladder cancer cells in vitro

  2017cites this paper
• Effect of 5-Fluorouracil on Thymidine Phosphorylase Activity in Model Experiment

  2016cites this paper
• Effects of Arachidin-1 and Arachidin-3 on Human Colon Cancer Cells

  2016influential citation
• Thymidine Phosphorylase in Cancer; Enemy or Friend?

  2016cites this paper
• Do endometrial cancer patients benefit from metformin intake?

  2015cites this paper
• The influence of 5-fluorouracil on activity of thymidine phosphorylase in gastric adenocarcinoma and normal adjacent tissue.

  2014cites this paper
• Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.

  2014cites this paper
• Metformin in lung cancer: rationale for a combination therapy

  2013cites this paper
• Customizing chemotherapy in thoracic malignancies based on ERCC1 expression

  2013cites this paper